Alimera sciences to present at the h.c. wainwright bioconnect 2021 virtual conference

Atlanta, jan. 05, 2021 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (alimera), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces that president and ceo rick eiswirth will present at the h.c. wainwright bioconnect 2021 virtual conference taking place january 11-14, 2021.

ALIM Ratings Summary

ALIM Quant Ranking